Patheon

Patheon N.V. is a provider of outsourced pharmaceutical development and manufacturing services, primarily serving the pharmaceutical and biotechnology industries. The company operates through three main segments: Drug Product Services, Pharmaceutical Development Services, and Drug Substance Services. It offers a comprehensive range of services, including formulation development, clinical and commercial-scale manufacturing, packaging, and lifecycle management for both small molecule and large molecule biological drugs. Patheon specializes in various dosage forms, including solid, semi-solid, liquid, and sterile products, and caters to diverse needs such as high-potency and controlled-release formulations. Its global reach extends to approximately 120 countries, delivering products and services that support drug development and commercialization. Founded in 1974 and headquartered in Durham, North Carolina, Patheon operates as a subsidiary of Thermo Fisher Scientific since its name change in 2016.

Rebecca Holland New

Corporate Officer and Executive Vice President, Enterprise-wide Operations

1 past transactions

Gallus BioPharmaceuticals

Acquisition in 2014
Gallus Biopharmaceuticals, LLC, a contract manufacturer, supplies clinical and commercial bulk biologics to the biopharmaceutical industry in the United States and internationally. It also provides process development, analytical development, process validation, cell banking, stability testing, QA/QC, and regulatory support solutions. The company was founded in 2010 and is based in Wellesley, Massachusetts.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.